Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

BLCO

Bausch plus Lomb (BLCO)

Bausch plus Lomb Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:BLCO
DateHeureSourceTitreSymboleSociété
07/05/202415h09IH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:BLCOBausch plus Lomb Corporation
06/05/202422h34IH Market NewsU.S. Stocks See Further Upside Amid Renewed Interest Rate OptimismNYSE:BLCOBausch plus Lomb Corporation
01/05/202412h58Business WireBausch + Lomb Announces First-Quarter 2024 ResultsNYSE:BLCOBausch plus Lomb Corporation
29/04/202413h00Business WireBausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
25/04/202414h30Business WireBausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry EyesNYSE:BLCOBausch plus Lomb Corporation
18/04/202413h00Business WireBausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling ProgramsNYSE:BLCOBausch plus Lomb Corporation
15/04/202418h00Business WireBausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1NYSE:BLCOBausch plus Lomb Corporation
27/03/202412h00Business WireBausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
04/03/202423h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
28/02/202414h12Edgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
28/02/202414h00Business WireBausch + Lomb Announces Appointment of Karen L. Ling to Board of DirectorsNYSE:BLCOBausch plus Lomb Corporation
21/02/202413h00GlobeNewswire Inc.Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEONYSE:BLCOBausch plus Lomb Corporation
21/02/202412h58Business WireBausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 GuidanceNYSE:BLCOBausch plus Lomb Corporation
05/02/202418h00Business WireBausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21NYSE:BLCOBausch plus Lomb Corporation
08/01/202412h59Business WireBausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction SurgeryNYSE:BLCOBausch plus Lomb Corporation
03/01/202415h00Business WireBausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:BLCOBausch plus Lomb Corporation
15/11/202312h59Business WireBausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling ProgramsNYSE:BLCOBausch plus Lomb Corporation
13/11/202322h47Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:BLCOBausch plus Lomb Corporation
01/11/202322h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BLCOBausch plus Lomb Corporation
01/11/202311h58Business WireBausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 GuidanceNYSE:BLCOBausch plus Lomb Corporation
26/10/202312h59Business WireBausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
16/10/202318h00Business WireBausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1NYSE:BLCOBausch plus Lomb Corporation
04/10/202312h59Business WireBausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
29/09/202316h00Business WireBausch + Lomb Completes Acquisition of XIIDRA®NYSE:BLCOBausch plus Lomb Corporation
26/09/202312h59Business WireBausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the United StatesNYSE:BLCOBausch plus Lomb Corporation
20/09/202312h59Business WireBausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award WinnersNYSE:BLCOBausch plus Lomb Corporation
14/09/202323h25Business WireBausch + Lomb Announces Pricing of Senior Secured Notes OfferingNYSE:BLCOBausch plus Lomb Corporation
12/09/202312h59Business WireBausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United StatesNYSE:BLCOBausch plus Lomb Corporation
11/09/202313h07Business WireBausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA®NYSE:BLCOBausch plus Lomb Corporation
06/09/202323h58Business WireBausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®NYSE:BLCOBausch plus Lomb Corporation
 Showing the most relevant articles for your search:NYSE:BLCO

Dernières Valeurs Consultées

Delayed Upgrade Clock